Umbilical blood transplant benefits children with myelomonocytic leukemia

10/9/2013 | Family Practice News

Juvenile myelomonocytic leukemia patients who were diagnosed before 1.4 years of age and had greater human leukocyte antigens compatibility showed substantially better survival rates following unrelated donor umbilical cord blood transplantation, according to a retrospective analysis. The five-year disease-free survival rate of patients who underwent the procedure was 44%, researchers from the University of Pavia wrote in the journal Blood.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY